KZR vs MKC · $53.9M cap vs P/E 8.4, rev $3.81B
Kezar Life Sciences Inc (KZR) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
KZR currently screens at market cap $53.9M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the KZR and MKC stock pages for the full models.
Not investment advice.